Fieldpoint Private Securities LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,901 shares of the company’s stock, valued at approximately $462,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Bronfman E.L. Rothschild L.P. raised its stake in shares of Cardinal Health by 31.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after purchasing an additional 382 shares in the last quarter. Advisory Services Network LLC raised its stake in shares of Cardinal Health by 18.4% in the second quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock valued at $136,000 after purchasing an additional 270 shares in the last quarter. Dupont Capital Management Corp acquired a new position in shares of Cardinal Health in the second quarter valued at $164,000. First Personal Financial Services raised its stake in shares of Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after purchasing an additional 1,238 shares in the last quarter. Finally, Sun Life Financial INC raised its stake in shares of Cardinal Health by 16,228.6% in the second quarter. Sun Life Financial INC now owns 2,286 shares of the company’s stock valued at $178,000 after purchasing an additional 2,272 shares in the last quarter. 88.47% of the stock is owned by institutional investors.
Cardinal Health, Inc. (NYSE CAH) opened at $60.57 on Thursday. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.52 and a current ratio of 1.06. Cardinal Health, Inc. has a 12 month low of $54.66 and a 12 month high of $84.88. The stock has a market capitalization of $18,958.01, a price-to-earnings ratio of 11.44, a price-to-earnings-growth ratio of 1.74 and a beta of 0.85.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. During the same period in the prior year, the company posted $1.24 earnings per share. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. equities analysts anticipate that Cardinal Health, Inc. will post 4.97 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd will be paid a dividend of $0.4624 per share. The ex-dividend date is Friday, December 29th. This represents a $1.85 annualized dividend and a yield of 3.05%. Cardinal Health’s dividend payout ratio is currently 53.78%.
A number of brokerages recently commented on CAH. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research note on Thursday, October 12th. Deutsche Bank began coverage on Cardinal Health in a research note on Monday, December 4th. They issued a “hold” rating and a $64.00 target price for the company. Jefferies Group cut their target price on Cardinal Health from $77.00 to $67.00 and set a “hold” rating for the company in a research note on Tuesday, November 7th. Robert W. Baird restated a “hold” rating and issued a $73.00 target price on shares of Cardinal Health in a research note on Sunday, September 17th. Finally, Cowen upgraded Cardinal Health to a “buy” rating and set a $74.00 target price for the company in a research note on Tuesday, October 10th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $73.91.
COPYRIGHT VIOLATION NOTICE: “Fieldpoint Private Securities LLC Acquires New Stake in Cardinal Health, Inc. (CAH)” was published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.thelincolnianonline.com/2017/12/14/fieldpoint-private-securities-llc-acquires-new-stake-in-cardinal-health-inc-cah.html.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.